C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38,779 | -61.6% | 12,350 | -27.8% | 0.02% | -60.4% |
Q4 2022 | $100,902 | -40.3% | 17,102 | -11.4% | 0.05% | -20.9% |
Q3 2022 | $169,000 | +16.6% | 19,305 | +0.7% | 0.07% | +24.1% |
Q2 2022 | $145,000 | +13.3% | 19,169 | +263.4% | 0.05% | -5.3% |
Q1 2022 | $128,000 | -28.9% | 5,275 | -5.6% | 0.06% | -16.2% |
Q4 2021 | $180,000 | -20.0% | 5,589 | +10.8% | 0.07% | -31.3% |
Q3 2021 | $225,000 | +11.9% | 5,043 | -5.1% | 0.10% | +19.3% |
Q2 2021 | $201,000 | – | 5,312 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |